UK markets closed

Pfizer Inc. (PFE)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
25.89-0.70 (-2.63%)
At close: 04:00PM EST
25.93 +0.04 (+0.15%)
After hours: 05:33PM EST
Full screen
Trade prices are not sourced from all markets
Previous close26.59
Bid25.79 x 3100
Ask25.80 x 3000
Day's range25.61 - 26.46
52-week range25.61 - 42.22
Avg. volume46,809,205
Market cap146.195B
Beta (5Y monthly)0.56
PE ratio (TTM)69.97
EPS (TTM)0.37
Earnings date30 Apr 2024 - 06 May 2024
Forward dividend & yield1.68 (6.32%)
Ex-dividend date25 Jan 2024
1y target est29.75
  • Reuters

    GSK's new HIV drug formula could support longer dosing intervals

    GSK said on Monday a new formulation of its HIV prevention and treatment drug could potentially be administered at least every four months, an improvement from the previous requirement of dosing every two months. Data on the ultra-long-acting cabotegravir was presented at the Conference on Retroviruses and Opportunistic Infections by GSK's HIV-focused unit, ViiV Healthcare, which plans to conduct large-scale clinical trials later this year. The company has shifted its HIV focus to long-acting treatments and prevention therapies, amid a series of upcoming patent expiries, litigations and declining revenue from current bestsellers.

  • Zacks

    Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

  • Reuters

    Evonik says recovery unlikely in 2024, plans 2,000 job cuts

    German chemicals group Evonik Industries said on Monday it expected no signs of a recovery in 2024 and announced up to 2,000 job cuts worldwide by 2026 in a bid to cut costs. Evonik, whose products are used in items from animal feed and diapers to Pfizer/BioNTech's COVID-19 vaccine, expects 2024 adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) in the range of 1.7 billion to 2.0 billion euros ($1.84 billion - $2.17 billion).